🌟 Exciting News!

We’re proud to share that Dr. Selin Akpinar Adscheid has been selected for the Nucleate x Genentech BD101 Fellowship 2025 Cohort — one of only two participants from Germany and 25 worldwide (5% acceptance rate)!

The BD101 program unites rising biotech leaders to explore the foundations of business development through interactive lectures, expert discussions, and a final collaborative capstone project.

Hosted by Nucleate in close partnership with Genentech, this fellowship empowers graduate-level trainees to gain insights directly from one of the world’s leading biotech companies while building skills to drive innovation.